nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Methylprednisolone—psoriatic arthritis	0.101	0.248	CbGbCtD
Fulvestrant—CYP3A4—Triamcinolone—psoriatic arthritis	0.0763	0.188	CbGbCtD
Fulvestrant—CYP3A4—Betamethasone—psoriatic arthritis	0.0655	0.161	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—psoriatic arthritis	0.0646	0.159	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—psoriatic arthritis	0.061	0.15	CbGbCtD
Fulvestrant—CYP3A4—Dexamethasone—psoriatic arthritis	0.0381	0.0937	CbGbCtD
Fulvestrant—Injury—Prednisolone—psoriatic arthritis	0.00463	0.00779	CcSEcCtD
Fulvestrant—Diarrhoea—Auranofin—psoriatic arthritis	0.00449	0.00755	CcSEcCtD
Fulvestrant—Injury—Triamcinolone—psoriatic arthritis	0.00426	0.00717	CcSEcCtD
Fulvestrant—Injury—Methylprednisolone—psoriatic arthritis	0.00425	0.00715	CcSEcCtD
Fulvestrant—Vomiting—Auranofin—psoriatic arthritis	0.00417	0.00702	CcSEcCtD
Fulvestrant—Rash—Auranofin—psoriatic arthritis	0.00413	0.00696	CcSEcCtD
Fulvestrant—Dermatitis—Auranofin—psoriatic arthritis	0.00413	0.00696	CcSEcCtD
Fulvestrant—Nausea—Auranofin—psoriatic arthritis	0.00389	0.00656	CcSEcCtD
Fulvestrant—Injury—Betamethasone—psoriatic arthritis	0.00386	0.0065	CcSEcCtD
Fulvestrant—Injury—Dexamethasone—psoriatic arthritis	0.00386	0.0065	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00376	0.00634	CcSEcCtD
Fulvestrant—Inflammation—Methotrexate—psoriatic arthritis	0.00367	0.00618	CcSEcCtD
Fulvestrant—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00353	0.00594	CcSEcCtD
Fulvestrant—Influenza—Triamcinolone—psoriatic arthritis	0.00338	0.00569	CcSEcCtD
Fulvestrant—Injury—Prednisone—psoriatic arthritis	0.00336	0.00566	CcSEcCtD
Fulvestrant—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00301	0.00506	CcSEcCtD
Fulvestrant—Infestation—Methylprednisolone—psoriatic arthritis	0.00301	0.00506	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisolone—psoriatic arthritis	0.00296	0.00498	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisolone—psoriatic arthritis	0.00294	0.00496	CcSEcCtD
Fulvestrant—Sweating—Methylprednisolone—psoriatic arthritis	0.00288	0.00486	CcSEcCtD
Fulvestrant—Hepatic failure—Methotrexate—psoriatic arthritis	0.00287	0.00484	CcSEcCtD
Fulvestrant—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00272	0.00458	CcSEcCtD
Fulvestrant—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00271	0.00457	CcSEcCtD
Fulvestrant—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00271	0.00456	CcSEcCtD
Fulvestrant—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.0027	0.00455	CcSEcCtD
Fulvestrant—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00269	0.00452	CcSEcCtD
Fulvestrant—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00265	0.00447	CcSEcCtD
Fulvestrant—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00247	0.00416	CcSEcCtD
Fulvestrant—Haemoglobin—Betamethasone—psoriatic arthritis	0.00247	0.00416	CcSEcCtD
Fulvestrant—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00246	0.00413	CcSEcCtD
Fulvestrant—Haemorrhage—Betamethasone—psoriatic arthritis	0.00246	0.00413	CcSEcCtD
Fulvestrant—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00245	0.00413	CcSEcCtD
Fulvestrant—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00244	0.00411	CcSEcCtD
Fulvestrant—Depression—Prednisone—psoriatic arthritis	0.00237	0.004	CcSEcCtD
Fulvestrant—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00235	0.00396	CcSEcCtD
Fulvestrant—Angioedema—Prednisolone—psoriatic arthritis	0.00234	0.00394	CcSEcCtD
Fulvestrant—Breast disorder—Methotrexate—psoriatic arthritis	0.00233	0.00393	CcSEcCtD
Fulvestrant—Vertigo—Prednisolone—psoriatic arthritis	0.0023	0.00388	CcSEcCtD
Fulvestrant—Back pain—Triamcinolone—psoriatic arthritis	0.00228	0.00384	CcSEcCtD
Fulvestrant—Angiopathy—Dexamethasone—psoriatic arthritis	0.00223	0.00375	CcSEcCtD
Fulvestrant—Angiopathy—Betamethasone—psoriatic arthritis	0.00223	0.00375	CcSEcCtD
Fulvestrant—Angioedema—Triamcinolone—psoriatic arthritis	0.00215	0.00362	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—psoriatic arthritis	0.00215	0.00362	CcSEcCtD
Fulvestrant—Angioedema—Methylprednisolone—psoriatic arthritis	0.00215	0.00362	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—psoriatic arthritis	0.00214	0.0036	CcSEcCtD
Fulvestrant—Vertigo—Triamcinolone—psoriatic arthritis	0.00212	0.00356	CcSEcCtD
Fulvestrant—Vertigo—Methylprednisolone—psoriatic arthritis	0.00211	0.00356	CcSEcCtD
Fulvestrant—Connective tissue disorder—Prednisone—psoriatic arthritis	0.0021	0.00354	CcSEcCtD
Fulvestrant—Cough—Triamcinolone—psoriatic arthritis	0.00206	0.00346	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00202	0.0034	CcSEcCtD
Fulvestrant—Myalgia—Triamcinolone—psoriatic arthritis	0.00201	0.00338	CcSEcCtD
Fulvestrant—Arthralgia—Methylprednisolone—psoriatic arthritis	0.002	0.00337	CcSEcCtD
Fulvestrant—Myalgia—Methylprednisolone—psoriatic arthritis	0.002	0.00337	CcSEcCtD
Fulvestrant—Anxiety—Methylprednisolone—psoriatic arthritis	0.00199	0.00336	CcSEcCtD
Fulvestrant—Infestation—Methotrexate—psoriatic arthritis	0.00199	0.00335	CcSEcCtD
Fulvestrant—Infestation NOS—Methotrexate—psoriatic arthritis	0.00199	0.00335	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00199	0.00335	CcSEcCtD
Fulvestrant—Depression—Methotrexate—psoriatic arthritis	0.00198	0.00334	CcSEcCtD
Fulvestrant—Angioedema—Dexamethasone—psoriatic arthritis	0.00195	0.00329	CcSEcCtD
Fulvestrant—Angioedema—Betamethasone—psoriatic arthritis	0.00195	0.00329	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—psoriatic arthritis	0.00194	0.00327	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—psoriatic arthritis	0.00193	0.00325	CcSEcCtD
Fulvestrant—Vertigo—Betamethasone—psoriatic arthritis	0.00192	0.00323	CcSEcCtD
Fulvestrant—Vertigo—Dexamethasone—psoriatic arthritis	0.00192	0.00323	CcSEcCtD
Fulvestrant—Infection—Triamcinolone—psoriatic arthritis	0.00191	0.00322	CcSEcCtD
Fulvestrant—Sweating—Methotrexate—psoriatic arthritis	0.00191	0.00321	CcSEcCtD
Fulvestrant—Infection—Methylprednisolone—psoriatic arthritis	0.00191	0.00321	CcSEcCtD
Fulvestrant—Insomnia—Prednisolone—psoriatic arthritis	0.00189	0.00318	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00188	0.00317	CcSEcCtD
Fulvestrant—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00188	0.00317	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisolone—psoriatic arthritis	0.00188	0.00316	CcSEcCtD
Fulvestrant—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00186	0.00314	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—psoriatic arthritis	0.00186	0.00313	CcSEcCtD
Fulvestrant—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00186	0.00313	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00185	0.00312	CcSEcCtD
Fulvestrant—Myalgia—Dexamethasone—psoriatic arthritis	0.00182	0.00306	CcSEcCtD
Fulvestrant—Myalgia—Betamethasone—psoriatic arthritis	0.00182	0.00306	CcSEcCtD
Fulvestrant—Anxiety—Dexamethasone—psoriatic arthritis	0.00181	0.00305	CcSEcCtD
Fulvestrant—Anxiety—Betamethasone—psoriatic arthritis	0.00181	0.00305	CcSEcCtD
Fulvestrant—Haemoglobin—Methotrexate—psoriatic arthritis	0.0018	0.00302	CcSEcCtD
Fulvestrant—Pain—Prednisolone—psoriatic arthritis	0.00179	0.00301	CcSEcCtD
Fulvestrant—Haemorrhage—Methotrexate—psoriatic arthritis	0.00179	0.00301	CcSEcCtD
Fulvestrant—Hepatitis—Methotrexate—psoriatic arthritis	0.00179	0.00301	CcSEcCtD
Fulvestrant—Pharyngitis—Methotrexate—psoriatic arthritis	0.00177	0.00299	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00175	0.00295	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00175	0.00294	CcSEcCtD
Fulvestrant—Insomnia—Triamcinolone—psoriatic arthritis	0.00174	0.00293	CcSEcCtD
Fulvestrant—Insomnia—Methylprednisolone—psoriatic arthritis	0.00173	0.00292	CcSEcCtD
Fulvestrant—Infection—Betamethasone—psoriatic arthritis	0.00173	0.00292	CcSEcCtD
Fulvestrant—Infection—Dexamethasone—psoriatic arthritis	0.00173	0.00292	CcSEcCtD
Fulvestrant—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00173	0.00291	CcSEcCtD
Fulvestrant—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00172	0.0029	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—psoriatic arthritis	0.00172	0.0029	CcSEcCtD
Fulvestrant—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00171	0.00289	CcSEcCtD
Fulvestrant—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00171	0.00288	CcSEcCtD
Fulvestrant—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00171	0.00288	CcSEcCtD
Fulvestrant—Angioedema—Prednisone—psoriatic arthritis	0.0017	0.00286	CcSEcCtD
Fulvestrant—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00169	0.00285	CcSEcCtD
Fulvestrant—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00169	0.00284	CcSEcCtD
Fulvestrant—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00169	0.00284	CcSEcCtD
Fulvestrant—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00169	0.00284	CcSEcCtD
Fulvestrant—Vertigo—Prednisone—psoriatic arthritis	0.00167	0.00282	CcSEcCtD
Fulvestrant—Anorexia—Dexamethasone—psoriatic arthritis	0.00166	0.0028	CcSEcCtD
Fulvestrant—Anorexia—Betamethasone—psoriatic arthritis	0.00166	0.0028	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—psoriatic arthritis	0.00166	0.0028	CcSEcCtD
Fulvestrant—Fatigue—Triamcinolone—psoriatic arthritis	0.00166	0.00279	CcSEcCtD
Fulvestrant—Fatigue—Methylprednisolone—psoriatic arthritis	0.00165	0.00278	CcSEcCtD
Fulvestrant—Pain—Triamcinolone—psoriatic arthritis	0.00164	0.00277	CcSEcCtD
Fulvestrant—Angiopathy—Methotrexate—psoriatic arthritis	0.00162	0.00273	CcSEcCtD
Fulvestrant—Immune system disorder—Methotrexate—psoriatic arthritis	0.00161	0.00272	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00159	0.00268	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00159	0.00268	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—psoriatic arthritis	0.00158	0.00267	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—psoriatic arthritis	0.00158	0.00267	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—psoriatic arthritis	0.00158	0.00266	CcSEcCtD
Fulvestrant—Insomnia—Betamethasone—psoriatic arthritis	0.00158	0.00266	CcSEcCtD
Fulvestrant—Insomnia—Dexamethasone—psoriatic arthritis	0.00158	0.00266	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00157	0.00265	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00157	0.00264	CcSEcCtD
Fulvestrant—Paraesthesia—Betamethasone—psoriatic arthritis	0.00157	0.00264	CcSEcCtD
Fulvestrant—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00157	0.00264	CcSEcCtD
Fulvestrant—Malnutrition—Methotrexate—psoriatic arthritis	0.00156	0.00262	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00154	0.00259	CcSEcCtD
Fulvestrant—Dyspepsia—Betamethasone—psoriatic arthritis	0.00154	0.00259	CcSEcCtD
Fulvestrant—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00154	0.00259	CcSEcCtD
Fulvestrant—Urticaria—Triamcinolone—psoriatic arthritis	0.00153	0.00257	CcSEcCtD
Fulvestrant—Urticaria—Methylprednisolone—psoriatic arthritis	0.00152	0.00257	CcSEcCtD
Fulvestrant—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00152	0.00256	CcSEcCtD
Fulvestrant—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00152	0.00255	CcSEcCtD
Fulvestrant—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00152	0.00255	CcSEcCtD
Fulvestrant—Decreased appetite—Betamethasone—psoriatic arthritis	0.00152	0.00255	CcSEcCtD
Fulvestrant—Infection—Prednisone—psoriatic arthritis	0.00151	0.00254	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00151	0.00254	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00151	0.00254	CcSEcCtD
Fulvestrant—Back pain—Methotrexate—psoriatic arthritis	0.0015	0.00253	CcSEcCtD
Fulvestrant—Fatigue—Dexamethasone—psoriatic arthritis	0.0015	0.00253	CcSEcCtD
Fulvestrant—Fatigue—Betamethasone—psoriatic arthritis	0.0015	0.00253	CcSEcCtD
Fulvestrant—Pain—Betamethasone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Fulvestrant—Pain—Dexamethasone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Fulvestrant—Nervous system disorder—Prednisone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—psoriatic arthritis	0.00148	0.00248	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00147	0.00247	CcSEcCtD
Fulvestrant—Anorexia—Prednisone—psoriatic arthritis	0.00145	0.00244	CcSEcCtD
Fulvestrant—Anaemia—Methotrexate—psoriatic arthritis	0.00144	0.00242	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00143	0.0024	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00143	0.0024	CcSEcCtD
Fulvestrant—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00142	0.00239	CcSEcCtD
Fulvestrant—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00141	0.00238	CcSEcCtD
Fulvestrant—Vertigo—Methotrexate—psoriatic arthritis	0.0014	0.00235	CcSEcCtD
Fulvestrant—Leukopenia—Methotrexate—psoriatic arthritis	0.00139	0.00234	CcSEcCtD
Fulvestrant—Urticaria—Betamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Fulvestrant—Urticaria—Dexamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00138	0.00233	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—psoriatic arthritis	0.00138	0.00233	CcSEcCtD
Fulvestrant—Asthenia—Triamcinolone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Abdominal pain—Betamethasone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Body temperature increased—Betamethasone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Asthenia—Methylprednisolone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—psoriatic arthritis	0.00137	0.00231	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisone—psoriatic arthritis	0.00136	0.0023	CcSEcCtD
Fulvestrant—Pruritus—Triamcinolone—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Fulvestrant—Cough—Methotrexate—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Fulvestrant—Pruritus—Methylprednisolone—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Fulvestrant—Dyspepsia—Prednisone—psoriatic arthritis	0.00134	0.00225	CcSEcCtD
Fulvestrant—Arthralgia—Methotrexate—psoriatic arthritis	0.00132	0.00223	CcSEcCtD
Fulvestrant—Myalgia—Methotrexate—psoriatic arthritis	0.00132	0.00223	CcSEcCtD
Fulvestrant—Chest pain—Methotrexate—psoriatic arthritis	0.00132	0.00223	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Fulvestrant—Rash—Prednisolone—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00132	0.00221	CcSEcCtD
Fulvestrant—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00131	0.00221	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—psoriatic arthritis	0.00131	0.00221	CcSEcCtD
Fulvestrant—Headache—Prednisolone—psoriatic arthritis	0.00131	0.00221	CcSEcCtD
Fulvestrant—Constipation—Prednisone—psoriatic arthritis	0.0013	0.00219	CcSEcCtD
Fulvestrant—Dizziness—Triamcinolone—psoriatic arthritis	0.00127	0.00214	CcSEcCtD
Fulvestrant—Dizziness—Methylprednisolone—psoriatic arthritis	0.00127	0.00214	CcSEcCtD
Fulvestrant—Infection—Methotrexate—psoriatic arthritis	0.00126	0.00212	CcSEcCtD
Fulvestrant—Asthenia—Dexamethasone—psoriatic arthritis	0.00125	0.00211	CcSEcCtD
Fulvestrant—Asthenia—Betamethasone—psoriatic arthritis	0.00125	0.00211	CcSEcCtD
Fulvestrant—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00124	0.0021	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00124	0.00209	CcSEcCtD
Fulvestrant—Nausea—Prednisolone—psoriatic arthritis	0.00124	0.00209	CcSEcCtD
Fulvestrant—Pruritus—Dexamethasone—psoriatic arthritis	0.00123	0.00208	CcSEcCtD
Fulvestrant—Pruritus—Betamethasone—psoriatic arthritis	0.00123	0.00208	CcSEcCtD
Fulvestrant—Skin disorder—Methotrexate—psoriatic arthritis	0.00123	0.00208	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00123	0.00207	CcSEcCtD
Fulvestrant—Vomiting—Triamcinolone—psoriatic arthritis	0.00122	0.00206	CcSEcCtD
Fulvestrant—Vomiting—Methylprednisolone—psoriatic arthritis	0.00122	0.00205	CcSEcCtD
Fulvestrant—Rash—Triamcinolone—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Fulvestrant—Dermatitis—Triamcinolone—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Fulvestrant—Anorexia—Methotrexate—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Fulvestrant—Rash—Methylprednisolone—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Fulvestrant—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Fulvestrant—Urticaria—Prednisone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Fulvestrant—Headache—Triamcinolone—psoriatic arthritis	0.0012	0.00203	CcSEcCtD
Fulvestrant—Headache—Methylprednisolone—psoriatic arthritis	0.0012	0.00202	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—psoriatic arthritis	0.0012	0.00202	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—psoriatic arthritis	0.0012	0.00202	CcSEcCtD
Fulvestrant—Diarrhoea—Betamethasone—psoriatic arthritis	0.00119	0.00201	CcSEcCtD
Fulvestrant—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00119	0.00201	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00116	0.00195	CcSEcCtD
Fulvestrant—Dizziness—Dexamethasone—psoriatic arthritis	0.00115	0.00194	CcSEcCtD
Fulvestrant—Dizziness—Betamethasone—psoriatic arthritis	0.00115	0.00194	CcSEcCtD
Fulvestrant—Insomnia—Methotrexate—psoriatic arthritis	0.00115	0.00193	CcSEcCtD
Fulvestrant—Nausea—Triamcinolone—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Fulvestrant—Paraesthesia—Methotrexate—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Fulvestrant—Nausea—Methylprednisolone—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Fulvestrant—Dyspnoea—Methotrexate—psoriatic arthritis	0.00113	0.00191	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisone—psoriatic arthritis	0.00112	0.00188	CcSEcCtD
Fulvestrant—Dyspepsia—Methotrexate—psoriatic arthritis	0.00112	0.00188	CcSEcCtD
Fulvestrant—Vomiting—Betamethasone—psoriatic arthritis	0.00111	0.00187	CcSEcCtD
Fulvestrant—Vomiting—Dexamethasone—psoriatic arthritis	0.00111	0.00187	CcSEcCtD
Fulvestrant—Decreased appetite—Methotrexate—psoriatic arthritis	0.0011	0.00186	CcSEcCtD
Fulvestrant—Rash—Dexamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Fulvestrant—Rash—Betamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Fulvestrant—Dermatitis—Dexamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Fulvestrant—Dermatitis—Betamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Fulvestrant—Fatigue—Methotrexate—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Fulvestrant—Headache—Betamethasone—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Fulvestrant—Headache—Dexamethasone—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Fulvestrant—Asthenia—Prednisone—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Fulvestrant—Pain—Methotrexate—psoriatic arthritis	0.00109	0.00183	CcSEcCtD
Fulvestrant—Pruritus—Prednisone—psoriatic arthritis	0.00107	0.00181	CcSEcCtD
Fulvestrant—Diarrhoea—Prednisone—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Fulvestrant—Nausea—Betamethasone—psoriatic arthritis	0.00104	0.00174	CcSEcCtD
Fulvestrant—Nausea—Dexamethasone—psoriatic arthritis	0.00104	0.00174	CcSEcCtD
Fulvestrant—Urticaria—Methotrexate—psoriatic arthritis	0.00101	0.0017	CcSEcCtD
Fulvestrant—Dizziness—Prednisone—psoriatic arthritis	0.001	0.00169	CcSEcCtD
Fulvestrant—Abdominal pain—Methotrexate—psoriatic arthritis	0.001	0.00169	CcSEcCtD
Fulvestrant—Body temperature increased—Methotrexate—psoriatic arthritis	0.001	0.00169	CcSEcCtD
Fulvestrant—Vomiting—Prednisone—psoriatic arthritis	0.000966	0.00163	CcSEcCtD
Fulvestrant—Rash—Prednisone—psoriatic arthritis	0.000958	0.00161	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—psoriatic arthritis	0.000957	0.00161	CcSEcCtD
Fulvestrant—Headache—Prednisone—psoriatic arthritis	0.000952	0.0016	CcSEcCtD
Fulvestrant—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000935	0.00158	CcSEcCtD
Fulvestrant—Asthenia—Methotrexate—psoriatic arthritis	0.000911	0.00153	CcSEcCtD
Fulvestrant—Nausea—Prednisone—psoriatic arthritis	0.000902	0.00152	CcSEcCtD
Fulvestrant—Pruritus—Methotrexate—psoriatic arthritis	0.000898	0.00151	CcSEcCtD
Fulvestrant—Diarrhoea—Methotrexate—psoriatic arthritis	0.000869	0.00146	CcSEcCtD
Fulvestrant—Dizziness—Methotrexate—psoriatic arthritis	0.000839	0.00141	CcSEcCtD
Fulvestrant—Vomiting—Methotrexate—psoriatic arthritis	0.000807	0.00136	CcSEcCtD
Fulvestrant—Rash—Methotrexate—psoriatic arthritis	0.0008	0.00135	CcSEcCtD
Fulvestrant—Dermatitis—Methotrexate—psoriatic arthritis	0.0008	0.00135	CcSEcCtD
Fulvestrant—Headache—Methotrexate—psoriatic arthritis	0.000795	0.00134	CcSEcCtD
Fulvestrant—Nausea—Methotrexate—psoriatic arthritis	0.000754	0.00127	CcSEcCtD
